Overview
Immunology Regulatory Landscape
The regulatory environment for immunology therapies involves specialized requirements from FDA Division of Rheumatology and Transplant Medicine, EMA CHMP Immunology Working Party, PMDA Immunology Review. This guide maps each requirement to ArcaScience's platform capabilities, demonstrating how AI-driven benefit-risk analysis aligns with and accelerates regulatory compliance.
Regulatory Requirements
Key Requirements by Agency
FDA Requirements
- ✓ JAK inhibitor boxed warning requirements
- ✓ Biosimilar interchangeability evidence standards
- ✓ REMS for immunosuppressive biologics
- ✓ Immunogenicity assessment guidance
- ✓ Post-marketing surveillance for biologics
EMA Requirements
- ✓ Biosimilar guideline requirements
- ✓ Immunogenicity assessment for biological products
- ✓ Cardiovascular safety monitoring for JAK inhibitors
- ✓ Extrapolation across therapeutic indications
PMDA Requirements
- ✓ Japan biosimilar approval pathway
- ✓ Post-marketing surveillance for biologics
- ✓ Immunology-specific safety monitoring requirements
ArcaScience Alignment
How ArcaScience Maps to Immunology Requirements
Data Coverage
Immunology-specific data from 47+ global sources, pre-harmonized and validated for regulatory submissions.
AI Models
Immunology-trained AI models for adverse event classification, signal detection, and benefit quantification with regulatory validation.
Regulatory Outputs
Pre-formatted outputs aligned with FDA Division of Rheumatology and Transplant Medicine and EMA CHMP Immunology Working Party submission requirements.
Download
Get the Full Immunology Regulatory Landscape
Complete the form below to receive the document via email.
Related Resources